50242-0145 Perjeta - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

50242-0145

Brand Name:

Perjeta

Generic Name:

Pertuzumab

Dosage Form Name:

INJECTION, SOLUTION, CONCENTRATE

Administration Route:

Intravenous

Substances:

Name: Pertuzumab

Strength: 30.0

Unit: mg/mL

Packages:

Code: 50242-0145-01

Description: 1 VIAL, SINGLE-USE in 1 CARTON (50242-145-01) / 14 mL in 1 VIAL, SINGLE-USE

Effective Date: June 8, 2012

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

HER2

Orphan Drug Designation:

Status:

In Use